|
This is an index of adverse event reports related to Labetalol. Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the adverse reaction. Or scroll down to view all available reports.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (4)
Cases resulting in a serious event (4)
Cases resulting in hospitalization (2)
Cases resulting in other serious reactions (2)
Adverse event in 53 year old male receiving Labetalol
Reported by a physician from United States on 2007-10-05
Patient: 53 year old male, weighing 96.4 kg (212.1 pounds)
Adverse reactions / side effects: Transplant Rejection, Orthostatic Hypotension
Adverse event resulted in: hospitalization
Suspect drug(s):
PEG-Interferon Alfa 2A (RO 25-8310)
Indication: Hepatitis C
Start date: 2006-03-03
PEG-Interferon Alfa 2A (RO 25-8310)
End date: 2006-04-27
PEG-Interferon Alfa 2A (RO 25-8310)
Start date: 2006-05-05
End date: 2006-05-31
PEG-Interferon Alfa 2A (RO 25-8310)
End date: 2006-07-06
Ribavirin
Dosage: dose was increased to 1200 mg daily on an unspecified date.
Administration route: Oral
Indication: Hepatitis C
Start date: 2006-03-03
Ribavirin
Administration route: Oral
End date: 2006-04-27
Ribavirin
Administration route: Oral
Start date: 2006-04-29
End date: 2006-06-21
Ribavirin
Dosage: form reported as pill.
Administration route: Oral
End date: 2006-07-06
Labetalol
Indication: Hypertension
Start date: 2005-11-18
End date: 2006-04-28
Other drugs received by patient: Calcium; Bactrim; Tramadol HCL; Magnesium Sulfate; Lactulose; Prednisone; Aciphex; Nystatin; Cyclosporine; Paxil; Trazodone HCL; Cardizem; Lopressor; Aspirin
Adverse event in 80 year old female receiving Labetalol
Reported by a consumer/non-health professional from United States on 2007-10-02
Patient: 80 year old female
Adverse reactions / side effects: Psychomotor Hyperactivity, Blood Pressure Inadequately Controlled, Optic Nerve Infarction, Loss of Consciousness
Suspect drug(s):
Hydrochlorothiazide
Dosage: 25 mg, unk
Indication: Hypertension
Labetalol
Indication: Hypertension
Atenolol
Dosage: 100 mg, unk
Indication: Hypertension
Atenolol
Dosage: 50 mg, unk
Lisinopril
Dosage: 20 mg, unk
Indication: Hypertension
Adverse event in 35 year old female receiving Labetalol
Reported by a individual with unspecified qualification on 2007-10-02
Patient: 35 year old female
Adverse reactions / side effects: Ischaemia, Drug Ineffective, Iatrogenic Injury, Vith Nerve Disorder, Vith Nerve Paralysis, Anaesthetic Complication, Headache, Diplopia, Caesarean Section, Intracranial Hypotension
Suspect drug(s):
Clonidine
Administration route: Oral
Indication: PRE-Eclampsia
Clonidine
Administration route: Oral
Hydralazine HCL
Administration route: Oral
Indication: PRE-Eclampsia
Hydralazine HCL
Administration route: Oral
Enalapril Maleate
Administration route: Oral
Indication: PRE-Eclampsia
Labetalol
Administration route: Oral
Indication: PRE-Eclampsia
Nifedipine
Administration route: Oral
Indication: PRE-Eclampsia
Prazosin HCL
Administration route: Oral
Indication: PRE-Eclampsia
Other drugs received by patient: Betamethasone; Magnesium Sulfate
Adverse event in male receiving Labetalol
Reported by a pharmacist from United States on 2007-02-14
Patient: male, weighing 93.4 kg (205.6 pounds)
Adverse reactions / side effects: Balance Disorder, Dizziness, Asthenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Bumetanide
Dosage: 2 mg daily
Clonidine
Dosage: 0.2 mg/24 h patch
Felodipine
Dosage: 2.5 mg daily
Fluoxetine
Dosage: 10 mg daily
Labetalol
Dosage: 400 mg bid
Spironolactone
Other drugs received by patient: Accu-Chek Comfort CV (Glucose) Test Strip; Acetaminophen; Albuterol / Ipratrop; Alcohol Prep PAD; Bumetanide; Clonidine; Felodipine; Fluoxetine HCL; NPH Insulin; Insulin Syrg; Labetalol HCL; Lancet, Techlite; Lovastatin; Mometasone Furoate; Ranitidine; Spironolactone; Tablet Cutter; Temazepam
|
